GUJINJEC
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
Get instant stock alerts
- Share Price
- Financials
- Revenue mix
- Shareholdings
- Peers
- Forensics
Share Price
Coming soon
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
Financials
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
| (In Cr.) |
|---|
| (In Cr.) | ||||
|---|---|---|---|---|
|
This data is currently unavailable for this company. |
| (In %) |
|---|
| (In Cr.) |
|---|
| Financial Year (In Cr.) |
|---|
Revenue mix
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Forensics
Recent events
-
News
-
Corporate Actions
Gujarat Inject Kerala Gets Purchase Order For 7041 Solar PV Modules Valued At 60.7 Million Rupees
March 16 (Reuters) - Gujarat Inject Kerala Ltd GINK.BO:
GETS PURCHASE ORDER FOR 7041 SOLAR PV MODULES VALUED AT 60.7 MILLION RUPEES
Source text: ID:nBSE1FgYBX
Further company coverage: GINK.BO
(([email protected];;))
March 16 (Reuters) - Gujarat Inject Kerala Ltd GINK.BO:
GETS PURCHASE ORDER FOR 7041 SOLAR PV MODULES VALUED AT 60.7 MILLION RUPEES
Source text: ID:nBSE1FgYBX
Further company coverage: GINK.BO
(([email protected];;))
Events:
More Nano Cap Ideas
See similar 'Nano' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Guj. Inject (Kerala) do?
Tarajyot Polymers Ltd, a subsidiary of the Government of Kerala, specializes in the production and distribution of pharmaceutical products and medical equipment. They offer a wide range of items including bulk drugs, formulation chemicals, intravenous fluids, and disposable medical instruments.
Who are the competitors of Guj. Inject (Kerala)?
Guj. Inject (Kerala) major competitors are Mercury Laboratories, Lactose India, Bal Pharma, Krebs Biochem.&Inds, Tyche Inds, Concord Drugs, Pharmaids Pharma. Market Cap of Guj. Inject (Kerala) is ₹107 Crs. While the median market cap of its peers are ₹106 Crs.
Is Guj. Inject (Kerala) financially stable compared to its competitors?
Guj. Inject (Kerala) seems to be less financially stable compared to its competitors. Altman Z score of Guj. Inject (Kerala) is 0 and is ranked 7 out of its 8 competitors.
Does Guj. Inject (Kerala) pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Guj. Inject (Kerala) latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Guj. Inject (Kerala) allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Guj. Inject (Kerala) balance sheet?
Guj. Inject (Kerala) balance sheet is weak and might have solvency issues
Is the profitablity of Guj. Inject (Kerala) improving?
Yes, profit is increasing. The profit of Guj. Inject (Kerala) is ₹0.08 Crs for Mar 2024, ₹0.04 Crs for Mar 2023 and ₹0 Crs for Mar 2022
Is the debt of Guj. Inject (Kerala) increasing or decreasing?
Yes, The net debt of Guj. Inject (Kerala) is increasing. Latest net debt of Guj. Inject (Kerala) is -₹0.23 Crs as of Sep-25. This is greater than Mar-24 when it was -₹5.73 Crs.
Is Guj. Inject (Kerala) stock expensive?
Yes, Guj. Inject (Kerala) is expensive. Latest PE of Guj. Inject (Kerala) is 418, while 3 year average PE is 122. Also latest EV/EBITDA of Guj. Inject (Kerala) is 812 while 3yr average is 103.
Has the share price of Guj. Inject (Kerala) grown faster than its competition?
Guj. Inject (Kerala) has given better returns compared to its competitors. Guj. Inject (Kerala) has grown at ~99.08% over the last 3yrs while peers have grown at a median rate of 9.08%
Is the promoter bullish about Guj. Inject (Kerala)?
There is Insufficient data to gauge this.
Are mutual funds buying/selling Guj. Inject (Kerala)?
There is Insufficient data to gauge this.
